QQ客服 官方微博 反馈留言

	Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification
	Yao, Y.; Chi, Y.; Fang, Z.; Wang, S.; Huang, G.; Cai, Q.; Shang, G.; Wang, G.; Qu, G.; Wu, Q.
	2018
卷号	29
ISSN号	0923-7534
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6349037
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yao, Y.,Chi, Y.,Fang, Z.,et al. Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification[J],2018,29.
APA	Yao, Y..,Chi, Y..,Fang, Z..,Wang, S..,Huang, G..,...&Cai, J..(2018).Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification.,29.
MLA	Yao, Y.,et al."Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification".29(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。